Unspecified nephritic syndrome with dense deposit disease
ICD-10 N05.6 is a billable code used to indicate a diagnosis of unspecified nephritic syndrome with dense deposit disease.
Unspecified nephritic syndrome with dense deposit disease is a condition characterized by the presence of nephritis and nephrotic syndrome features, primarily due to dense deposit disease (DDD), a form of membranoproliferative glomerulonephritis. Patients typically present with symptoms such as proteinuria, hematuria, and edema. The pathophysiology involves the deposition of complement component C3 in the glomerular basement membrane, leading to inflammation and damage. Renal biopsy findings often reveal a characteristic pattern of glomerular changes, including mesangial proliferation and dense deposits in the glomerular capillary walls. Management by nephrology specialists may include corticosteroids, immunosuppressive agents, and supportive care to control symptoms and prevent progression to end-stage renal disease. Accurate coding is essential for appropriate treatment and reimbursement, as well as for tracking the epidemiology of this condition.
Detailed clinical notes including symptoms, lab results, and treatment plans.
Patients presenting with edema, hypertension, and abnormal urinalysis findings.
Ensure clear documentation of renal function tests and biopsy results to support the diagnosis.
Comprehensive reports on renal biopsy findings, including histological analysis.
Evaluation of renal biopsies for suspected glomerular diseases.
Pathology reports must clearly indicate the presence of dense deposits and any associated glomerular changes.
Used to confirm diagnosis of nephritic syndrome with dense deposit disease.
Biopsy report must detail findings and correlate with clinical symptoms.
Nephrologists must ensure that the biopsy is indicated based on clinical presentation.
Key symptoms include hematuria, proteinuria, edema, and hypertension. Patients may also experience fatigue and decreased urine output.
